Prelude Capital Management, LLC Axsome Therapeutics, Inc. Transaction History
Prelude Capital Management, LLC
- $1.5 Billion
- Q4 2024
A detailed history of Prelude Capital Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 7,200 shares of AXSM stock, worth $898,272. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,200Holding current value
$898,272% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AXSM
# of Institutions
352Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$505 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$487 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$412 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$183 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$173 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.35B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...